Strand Therapeutics Inc

Call
Website
20 Overland St Ste 1
Boston, MA 02215
+1 (617) 993-9271
https://www.strandtx.com

Strand Therapeutics Inc., based in Boston, MA, is pioneering the development of programmable long-acting mRNA therapeutics aimed at delivering precise, multi-functional treatments for serious diseases, including cancer. By employing advanced genetic circuits, the company's innovative approach allows mRNA to activate therapeutic responses only in diseased cells, thereby enhancing efficacy and minimizing side effects.

Co-founded by leading researchers from the MIT Synthetic Biology Center, Strand has created a unique programming language for mRNA that facilitates sophisticated control over protein expression. The company's mission is to transform patient lives through targeted, potentially curative mRNA medicines while exploring strategic partnerships to expand its groundbreaking programs.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Ultivue Inc

Ultivue Inc., based in Cambridge, MA, specializes in empowering scientists in the field of precision cancer therapies through its proprietary InSituPlex technology and advanced AI-driven spatial analysis. The company offers a range of biomarker panels, including the OmniVUE Core and U-VUE Custom Biomarkers, designed to enhance biomarker strategies for detailed spatial insights. With a strong commitment to innovation, Ultivue provides services such as 12-plex assay services and a comprehensive resource center, enabling researchers to optimize their spatial phenomics assays. As a leader in spatial biology workflows, Ultivue continues to collaborate with industry partners to streamline research processes and advance cancer treatment strategies. Generated from the website
Health association

SOPHiA GENETICS, Inc

SOPHiA GENETICS, Inc., based in Boston, MA, is at the forefront of innovative solutions in data-driven medicine, specializing in genomic and radiomic analytics. The company serves a diverse range of stakeholders, including healthcare providers, biopharmaceutical companies, and multiple specialists across the medical field, aimed at enhancing diagnostics and treatment plans. With a commitment to open innovation and collaboration, SOPHiA GENETICS provides an advanced analytics platform known as SOPHiA DDM, which supports various medical applications such as oncology, genetic research, and rare disorder diagnostics. Through its suite of solutions, the company aims to facilitate a comprehensive understanding of diseases, ultimately improving patient outcomes across the globe. Generated from the website
Testing laboratories

Angio-Proteomie

Angio-Proteomie is a Boston-based company specializing in the production and distribution of a wide range of high-quality antibodies, primary cells, recombinant proteins, and custom-based services for research and therapeutic purposes. With a diverse catalog of products, including anti-human and anti-mouse antibodies, functional antibodies, signal transduction antibodies, and more, Angio-Proteomie is committed to providing researchers and scientists with the tools they need to advance their studies in various fields, such as angiogenesis, immunology, and cell biology.Generated from the website
United States›Massachusetts›Boston›Strand Therapeutics Inc

Partial Data by Infogroup (c) 2024. All rights reserved.